Regeneron’s Covid-19 antibody may help non-hospitalized patients recover faster, early data show
New data from the biotechnology firm Regeneron seem likely to add to the excitement about drugs called monoclonal antibodies as treatments for Covid-19, but experts caution more data will be needed to know how potentially beneficial the medicines are. In a notable finding, the data seem to show that theContinue Reading